Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus–coinfected Women | Zendy

Erin Kelly | Zendy; Jennifer L. Dodge | Zendy; Monika Sarkar | Zendy; Audrey L. French | Zendy; Phyllis C. Tien | Zendy; Marshall J. Glesby | Zendy; Elizabeth T. Golub | Zendy; Michael Augenbraun | Zendy; Michael Plankey | Zendy; Marion G. Peters | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus–coinfected Women

Author(s) -

Erin Kelly,

Jennifer L. Dodge,

Monika Sarkar,

Audrey L. French,

Phyllis C. Tien,

Marshall J. Glesby,

Elizabeth T. Golub,

Michael Augenbraun,

Michael Plankey,

Marion G. Peters

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw350

Subject(s) - medicine , hazard ratio , interquartile range , proportional hazards model , hepatitis c , gastroenterology , fibrosis , hepatitis c virus , confidence interval , immunology , virus

Marijuana (hereafter "tetrahydrocannabinol [THC]") use has been associated with liver fibrosis progression in retrospective analyses of patients with chronic hepatitis C (HCV). We studied long-term effects of THC on fibrosis progression in women coinfected with human immunodeficiency virus (HIV)/HCV enrolled in the Women's Interagency HIV Study (WIHS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research